tradingkey.logo
搜索

Cytek Biosciences Inc

CTKB
添加自选
4.590USD
+0.010+0.22%
收盘 07/02, 16:00美东报价延迟15分钟
590.05M总市值
亏损市盈率 TTM

关于 Cytek Biosciences Inc 公司

Cytek Biosciences, Inc. is a cell analysis solutions company. The Company is advancing the cell analysis tools by delivering high-resolution, high-content, and high-sensitivity cell analysis utilizing its patented Full Spectrum Profiling (FSP) technology. Its platform includes its core FSP instruments, the Cytek Aurora and Northern Lights systems and the Cytek Aurora CS cell sorter; the Cytek Orion reagent cocktail preparation system; the Enhanced Small Particle (ESP) detection technology; the flow cytometer and imaging products under the Amnis and Guava brands, and reagents, software and service to provide a comprehensive and integrated suite of solutions for its customers. Its Cytek Aurora and Northern Lights systems are used in the study of infectious diseases, immunology, immunotherapy, immuno-oncology, oncology, and drug discovery. The Cytek Orion reagent cocktail preparation system enables researchers to fully automate the preparation of antibody cocktails for flow cytometry.

Cytek Biosciences Inc简介

公司代码CTKB
公司名称Cytek Biosciences Inc
上市日期Jul 23, 2021
CEOJiang (Wenbin)
员工数量648
证券类型Ordinary Share
年结日Jul 23
公司地址47215 Lakeview Boulevard
城市FREMONT
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编94538
电话18779229835
网址https://cytekbio.com
公司代码CTKB
上市日期Jul 23, 2021
CEOJiang (Wenbin)

Cytek Biosciences Inc公司高管

名称
名称/职务
职务
持股
持股变动
Dr. Wenbin Jiang, Ph.D.
Dr. Wenbin Jiang, Ph.D.
Chairman of the Board, President, Chief Executive Officer, Co-Founder
Chairman of the Board, President, Chief Executive Officer, Co-Founder
5.48M
+1.00%
Dr. Ming Yan, Ph.D.
Dr. Ming Yan, Ph.D.
Co-Founder, Chief Technology Officer, Director
Co-Founder, Chief Technology Officer, Director
4.80M
-2.83%
Ms. Valerie Barnett, J.D.
Ms. Valerie Barnett, J.D.
Chief Legal Officer and Corporate Secretary
Chief Legal Officer and Corporate Secretary
150.01K
+10.38%
Mr. Michael Holder
Mr. Michael Holder
Independent Director
Independent Director
60.69K
+72.45%
Dr. Vera Imper, Ph.D.
Dr. Vera Imper, Ph.D.
Independent Director
Independent Director
59.68K
+73.68%
Ms. Deborah J. Neff
Ms. Deborah J. Neff
Lead Independent Director
Lead Independent Director
59.68K
+73.68%
Mr. William (Bill) Mccombe
Mr. William (Bill) Mccombe
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Philippe Busque, Ph.D.
Dr. Philippe Busque, Ph.D.
Senior Vice President, Global Sales and Services
Senior Vice President, Global Sales and Services
--
--
Mr. Jack T. Ball, Jr.
Mr. Jack T. Ball, Jr.
Independent Director
Independent Director
--
--
名称
名称/职务
职务
持股
持股变动
Dr. Wenbin Jiang, Ph.D.
Dr. Wenbin Jiang, Ph.D.
Chairman of the Board, President, Chief Executive Officer, Co-Founder
Chairman of the Board, President, Chief Executive Officer, Co-Founder
5.48M
+1.00%
Dr. Ming Yan, Ph.D.
Dr. Ming Yan, Ph.D.
Co-Founder, Chief Technology Officer, Director
Co-Founder, Chief Technology Officer, Director
4.80M
-2.83%
Ms. Valerie Barnett, J.D.
Ms. Valerie Barnett, J.D.
Chief Legal Officer and Corporate Secretary
Chief Legal Officer and Corporate Secretary
150.01K
+10.38%
Mr. Michael Holder
Mr. Michael Holder
Independent Director
Independent Director
60.69K
+72.45%
Dr. Vera Imper, Ph.D.
Dr. Vera Imper, Ph.D.
Independent Director
Independent Director
59.68K
+73.68%
Ms. Deborah J. Neff
Ms. Deborah J. Neff
Lead Independent Director
Lead Independent Director
59.68K
+73.68%

常见问题

Cytek Biosciences Inc的前五大股东是谁?

Cytek Biosciences Inc 的前五大股东如下:Dr. Wenbin Jiang, Ph.D.

有多少机构持有Cytek Biosciences Inc(CTKB)的股份?

截至2026Q1,共有335家机构持有Cytek Biosciences Inc的股份,合计持有的股份价值约为84.13M,占公司总股份的65.16%。与2025Q4相比,机构持股有所增加,增幅为-7060937.00。

哪个业务部门对Cytek Biosciences Inc的收入贡献最大?

在2026Q1,Biotechnology, pharmaceutical, distributor and CRO业务部门对Cytek Biosciences Inc的收入贡献最大,创收116.73M,占总收入的57.93%。